Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist

Respiration. 2007;74(6):609-10. doi: 10.1159/000110205.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Aspergillosis / drug therapy*
  • Caspofungin
  • Chemotherapy, Adjuvant / methods
  • Drug Evaluation
  • Drug Therapy, Combination
  • Echinocandins / therapeutic use
  • Humans
  • Lipopeptides
  • Lung Diseases, Fungal / drug therapy*
  • Pyrimidines / therapeutic use
  • Treatment Outcome
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Caspofungin
  • Voriconazole